3T Biosciences is an immunotherapy company developing next-generation, transformative therapies for the treatment of solid tumors and other immune-mediated diseases in broad patie…
Portfolio
A closer look at the companies associated with this firm. Verified team members can update the portfolio after signing in.
This is the portfolio currently shown on the public firm page.
3T Biosciences is an immunotherapy company developing next-generation, transformative therapies for the treatment of solid tumors and other immune-mediated diseases in broad patie…
Capsida Biotherapeutics is focused on developing innovative gene therapies using its proprietary AAV (adeno-associated virus) platform to treat various diseases.
Electra Therapeutics is pioneering a new class of precision medicines focused on Signal Regulatory Protein (SIRP)-directed therapies aimed at improving outcomes for patients with…
Recludix Pharma is a clinical-stage biopharmaceutical company focused on developing innovative therapies for inflammatory diseases through SH2-targeted therapies and precision med…
Latigo Biotherapeutics is a clinical-stage biopharmaceutical company committed to developing innovative non-opioid pain medicines designed to rapidly and effectively stop the tran…
Kyverna is a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases. Their lead CAR T-cell…
Acelyrin, Inc. is a late-stage clinical biopharma company focused on accelerating the development and delivery of transformative medicines in immunology.
Arsenal Biosciences, Inc. is a clinical stage, programmable cell therapy company focused on solid tumor cell therapies to defeat cancer. With a programmable and computationally dr…
Borealis Biosciences was founded on the premise that a convergence of scientific and translational breakthroughs is enabling the field of RNA medicines to treat kidney diseases an…
Kate Therapeutics is a next-generation gene therapy company focused on developing innovative treatments for genetic skeletal muscle and heart diseases, including Duchenne muscular…
Neuron23 is focused on developing precision medicine approaches to improve the lives of people with Parkinson’s disease, leveraging data science and human genetics.
Vedana Therapeutics is developing innovative medicines to help patients achieve migraine freedom, focusing on next-generation therapies that target PACAP and other pathways beyond…
AllRock Bio is a clinical-stage biotechnology company focused on advancing impactful therapies for cardiopulmonary diseases, particularly pulmonary arterial hypertension and inter…